A BRISTOL TENNESSEE PHARMACEUTICALS COMPANY IS REPORTING A NOT-SO-GOOD FIRST QUARTER. KING PHARMACEUTICALS HAD A NET LOSS OF 11 MILLION COMPARED TO NET EARNINGS OF 86 MILLION IN THE FIRST QUARTER A YEAR AGO. JOE SQUICCIARINO IS THE COMPANY’S CHIEF FINANCIAL OFFICER……

THAT REPRESENTS A DECREASE OF THREE MILLION DOLLARS IN TOTAL REVIEWS FROM A YEAR AGO. COMPANY CHAIRMAN, PRESIDENT AND CEO BRIAN MARKISON, TALKS ABOUT THE STATUS OF APPROVAL FOR ONE OF THEIR NEW DRUG APPLICATIONS…..

KING IS A VERTICALLY INTEGRATED BRANDED PHARMACEUTICAL COMPANY.